Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines.

White FC, Carroll SM, Kamps MP.

Growth Factors. 1995;12(4):289-301.

PMID:
8930020
[PubMed - indexed for MEDLINE]
2.

Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.

Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E, Oldfield EH, Klausner RD, Linehan WM.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10589-94.

PMID:
8855222
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Post-transcriptional regulation of vascular endothelial growth factor by hypoxia.

Levy AP, Levy NS, Goldberg MA.

J Biol Chem. 1996 Feb 2;271(5):2746-53.

PMID:
8576250
[PubMed - indexed for MEDLINE]
Free Article
4.

Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis.

Kolch W, Martiny-Baron G, Kieser A, Marmé D.

Breast Cancer Res Treat. 1995;36(2):139-55. Review.

PMID:
8534863
[PubMed - indexed for MEDLINE]
5.

Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.

Shima DT, Adamis AP, Ferrara N, Yeo KT, Yeo TK, Allende R, Folkman J, D'Amore PA.

Mol Med. 1995 Jan;1(2):182-93.

PMID:
8529097
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin.

Goldberg MA, Schneider TJ.

J Biol Chem. 1994 Feb 11;269(6):4355-9.

PMID:
8308005
[PubMed - indexed for MEDLINE]
Free Article
7.

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.

Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A.

Nature. 1994 Feb 10;367(6463):576-9.

PMID:
8107827
[PubMed - indexed for MEDLINE]
8.

Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.

Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M.

Cancer Res. 1994 Sep 15;54(18):4845-7.

PMID:
8069849
[PubMed - indexed for MEDLINE]
Free Article
9.

Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HP, Laidlaw J, Li FP, et al.

Am J Hum Genet. 1994 Dec;55(6):1092-102. Erratum in: Am J Hum Genet 1995 Jan;56(1):356.

PMID:
7977367
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, et al.

Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9700-4.

PMID:
7937876
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Mutations of the VHL tumour suppressor gene in renal carcinoma.

Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, et al.

Nat Genet. 1994 May;7(1):85-90.

PMID:
7915601
[PubMed - indexed for MEDLINE]
12.

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.

Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, et al.

Hum Mol Genet. 1994 Dec;3(12):2169-73.

PMID:
7881415
[PubMed - indexed for MEDLINE]
13.

Frequent overexpression of vascular endothelial growth factor gene in human renal cell carcinoma.

Sato K, Terada K, Sugiyama T, Takahashi S, Saito M, Moriyama M, Kakinuma H, Suzuki Y, Kato M, Kato T.

Tohoku J Exp Med. 1994 Jul;173(3):355-60.

PMID:
7846687
[PubMed - indexed for MEDLINE]
Free Article
14.

Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.

Linehan WM, Lerman MI, Zbar B.

JAMA. 1995 Feb 15;273(7):564-70. Review. No abstract available.

PMID:
7837390
[PubMed - indexed for MEDLINE]
15.

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.

Levy AP, Levy NS, Wegner S, Goldberg MA.

J Biol Chem. 1995 Jun 2;270(22):13333-40.

PMID:
7768934
[PubMed - indexed for MEDLINE]
Free Article
16.

Regulation of vascular endothelial growth factor in cardiac myocytes.

Levy AP, Levy NS, Loscalzo J, Calderone A, Takahashi N, Yeo KT, Koren G, Colucci WS, Goldberg MA.

Circ Res. 1995 May;76(5):758-66.

PMID:
7728992
[PubMed - indexed for MEDLINE]
Free Article
17.

Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.

Kondo S, Asano M, Suzuki H.

Biochem Biophys Res Commun. 1993 Aug 16;194(3):1234-41.

PMID:
7688963
[PubMed - indexed for MEDLINE]
18.

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.

Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N.

Nature. 1993 Apr 29;362(6423):841-4.

PMID:
7683111
[PubMed - indexed for MEDLINE]
19.

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.

Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG Jr.

Science. 1995 Sep 8;269(5229):1444-6.

PMID:
7660130
[PubMed - indexed for MEDLINE]
20.

Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II.

Aso T, Lane WS, Conaway JW, Conaway RC.

Science. 1995 Sep 8;269(5229):1439-43.

PMID:
7660129
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk